Post-approval studies (Phase 4)UnknownNCT00487630
What this trial is testing
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
Who this might be right for
Fabry Disease
Assistance Publique - Hôpitaux de Paris 34